DIAGAST
Maxence Torris is a financial controller with extensive experience in strategic management and operational leadership, particularly at DIAGAST since September 2015. Maxence has played a key role in developing business intelligence tools, refining pricing strategies, and optimizing supply chain processes. In previous positions, responsibilities included teaching accounting and management at the University of Lille 2, where insights were shared with students in the domains of sports organizations, as well as managing financial and accounting tasks within the university. Maxence's educational background includes a Master's degree in Management Sciences with a focus on control and consultancy, alongside various MOOCs covering diverse topics such as project management, sports business, and supply chain logistics. Proficient in software like SAP and Microsoft Excel, Maxence demonstrates a strong blend of analytical skills and practical experience in finance and process improvement.
This person is not in any teams
DIAGAST
1 followers
Receiving blood is receiving life. DIAGAST’s goal is to help healthcare professionals transmit life with the help of the best blood group determination technologies. Even though it is not always a matter of life and death, transfusion errors are never acceptable. Over the last 30 years, DIAGAST has developed unparalleled expertise and know-how in the transfusion sector. DIAGAST develops, manufactures and markets reagents (for blood group determination), miniaturized laboratories for manual analysis and automated systems. DIAGAST also ensures the research, manufacturing and marketing of all its products. Moreover, DIAGAST offers a wide range of related services, such as a training center for their automated systems, a hotline and on-site follow-up on automaton calibration. We even make control and measurement tools available over the Internet. DIAGAST is now the worldwide leader in the marketing and development of reagents and instrumentation systems that aim to ensure donor and patient compatibility during blood transfusions.